Supplier's Corner

Eye Pro MD

...

Related CONTENT

05.20.10

Valensa International has introduced Eye Pro MD, an eye health formulation that combines carotenoids astaxanthin, lutein and zeaxanthin along with a proprietary omega 3/phospholipid delivery system and vitamin D3. The formulation was developed based on results from several studies, including the CARMIS clinical trial (Carotenoids and Antioxidants in Age Related Maculopathy Italian Study), which was published in the journal Ophthalmology in 2008. For further information: www.usnutra.com

Related Searches

Related Knowledge Center

Suggested For You

OmniActive to Present Research on Bioactive Ingredients

OmniActive to Present Research on Bioactive Ingredients

Mixed Carotenoid Supplement May Help Obese Children

Mixed Carotenoid Supplement May Help Obese Children

Protecting Vision in the Digital Age

Protecting Vision in the Digital Age

Vitamin D Shows Promise in Reducing Cancer in Older Women

Vitamin D Shows Promise in Reducing Cancer in Older Women

Valensa to Commercialize Algae-Based Immune Health Ingredients

Valensa to Commercialize Algae-Based Immune Health Ingredients

Kappa Bioscience to Acquire European Distributor ppm.Ingredients

Kappa Bioscience to Acquire European Distributor ppm.Ingredients

Kemin’s ZeaONE Zeaxanthin Gains GRAS Status

Kemin’s ZeaONE Zeaxanthin Gains GRAS Status

Study Links Lutemax 2020 with Combination of Skin Health Outcomes

Study Links Lutemax 2020 with Combination of Skin Health Outcomes

Valensa Launches Chia Gold Stabilized Chia Seed Oil in EU

Valensa Launches Chia Gold Stabilized Chia Seed Oil in EU

FDA Approves Increase in Amount of Vitamin D Allowed in Milk, Milk Alternatives

FDA Approves Increase in Amount of Vitamin D Allowed in Milk, Milk Alternatives

AIDP Debuts High Quality Vitamin D3 Ingredient

AIDP Debuts High Quality Vitamin D3 Ingredient

Valensa Develops Omega-3 Phospholipid Complex

Valensa Develops Omega-3 Phospholipid Complex

Valensa Pioneers Ecologically Sustainable Omega-3 Phospholipid Complex

Valensa Pioneers Ecologically Sustainable Omega-3 Phospholipid Complex

Bionops Laboratory Presents Biomacula

Bionops Laboratory Presents Biomacula

Valensa Supplier Expands Natural Astaxanthin Biomass Capacity

Valensa Supplier Expands Natural Astaxanthin Biomass Capacity

Related Content

OmniActive to Present Research on Bioactive Ingredients

Company to discuss how macular carotenoids protect from blue light and new applications for bioavailable curcumin.
05.08.17
Antioxidants | Breaking News | Infant & Children's Health | Research | Research News | Weight Management/Weight Loss

Mixed Carotenoid Supplement May Help Obese Children

After 6 months, subjects demonstrated reduced BMI, waist to height ratio, and other positive metrics.
05.02.17
Consumer Trends | Eye Health | Healthcare Trends | Herbs & Botanicals | Marine Nutraceuticals | Minerals | Omega-3s | Vitamins

Protecting Vision in the Digital Age

Exposure to blue light from digital screens has opened the eye health market to a broader spectrum of consumers.
By Sean Moloughney, Editor 05.01.17
Cancer Risk | Minerals | Research | Vitamins | Women's Health

Vitamin D Shows Promise in Reducing Cancer in Older Women

Higher blood levels of 25(OH)D were associated with lower cancer risk, according to an RCT published in JAMA.
Sean Moloughney, Editor 04.04.17
Green Foods | Immune Function | Supplier News

Valensa to Commercialize Algae-Based Immune Health Ingredients

Company advancing into human clinical trials on Immunum line.
01.17.17